Author

D. Hollern

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:mouse· 2 Assay:scRNA-seq· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Approach:deep learning· 1

Frequent Co-Authors

E. R. Andrechek· 2 shared J. P. Rennhack· 2 shared R. Kubiak· 2 shared A. V. Perry· 1 shared B. To· 1 shared C. Broeker· 1 shared C. Hamor· 1 shared C. Perou· 1 shared

Activity by Year

2021-2021 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

E. R. Andrechek

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Insight into mammary gland development and tumor prevention in a newly developed metastatic mouse model of breast cancer

B. To, C. Broeker, J.-R. Jhan, R. Rempel, J. P. Rennhack, D. Hollern, L. Jackson, D. Judah, M. Swiatnicki, E. Bylett, R. Kubiak, J. Honeysett, S. Reaz, J. R. Nevins, E. R. Andrechek

This study investigates the role of E2F5 in mammary gland development and tumor prevention using a mouse model, finding that its loss leads to dysregulated Cyclin D1 and metastatic breast tumors.

bioRxiv · Sep 24, 2021 · PreprintCancer Biology

Elevated phosphorylation of EGFR in NSCLC due to mutations in PTPRH

M. R. Swiatnicki, J. P. Rennhack, D. Hollern, A. V. Perry, R. Kubiak, S. M. Riveria Riveria, S. O'Reilly, E. R. Andrechek

This paper shows that PTPRH mutations in NSCLC lead to elevated EGFR phosphorylation, which can be targeted by existing EGFR inhibitors.

bioRxiv · Sep 14, 2021Cancer Biology

Chemotherapy coupled to macrophage inhibition leads to enhanced T and B cell infiltration and durable triple negative breast cancer regression

S. Singh, N. Lee, D. Pedroza, I. Bado, C. Hamor, L. Zhang, S. Aguirre, J. Hu, Y. Shen, Y. Xu, Y. Gao, N. Zhan, S.-H. Chen, Y.-W. Wan, Z. Liu, , J. M. Rosen

bioRxiv · Feb 22, 2021 · PreprintCancer Biology